Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
Dendritic cells (DCs) possess the specialized potential to present exogenously derived antigen to cytotoxic T lymphocytes to elicit an immune response. This process, termed cross presentation, is crucial in the generation of immune response to viruses, tumors and in autoimmune disease. The ability o...
Hauptverfasser: | Sachamitr, P, Fairchild, P |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
2012
|
Ähnliche Einträge
Ähnliche Einträge
-
iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
von: Horton, C, et al.
Veröffentlicht: (2019) -
Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.
von: Sachamitr, P, et al.
Veröffentlicht: (2014) -
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
von: Sachamitr, P, et al.
Veröffentlicht: (2018) -
Induced pluripotent stem cells: Challenges and opportunities for cancer immunotherapy
von: Patty eSachamitr, et al.
Veröffentlicht: (2014-04-01) -
STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy
von: Nguyen Thi Nguyen, et al.
Veröffentlicht: (2024-12-01)